Hepatitis B Immune Globulin Clinical Trials For HBV Prevention In Liver Transplant Patients To Be Discussed By Committee

Nabi Pharmaceuticals expects FDA action on Nabi-HB immune globulin BLA by mid-2004. Committee will also discuss supplemental testing for HIV and HCV, and platelet apheresis quality control.